Tools for Dealing with Radiation Exposures: IARPA Invests $3.8M from TEI-REX Program Biodetection September 3, 2024 …
New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health Emergencies Contracts + Grants August 27, 2024 …
Disappointing Results for Tecovirimat Mpox Trial in the DRC Medical Countermeasures August 15, 2024 …
Lassa Fever Vaccine Study Supports Advancement to Phase I Trial Medical Countermeasures August 14, 2024 …
Are We There Yet? Agent Agnostic Metagenome Sequencing for Biothreat Detection Biodetection July 31, 2024 …
Thylacine Biotherapeutics Earns Top Honor in Medical Threat Reduction Challenge Medical Countermeasures July 9, 2024 …
CDC Health Alert: Increased Risk of Dengue Virus Infections in the United States Infectious Diseases June 25, 2024 …
